Title : MARK2 enhances cisplatin resistance via PI3K/AKT/NF-κB signaling pathway in osteosarcoma cells.

Pub. Date : 2020

PMID : 32509178






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MARK2 enhances cisplatin resistance via PI3K/AKT/NF-kappaB signaling pathway in osteosarcoma cells. Cisplatin AKT serine/threonine kinase 1 Homo sapiens